An Extension Study to Evaluate the Long Term Safety, Tolerability and Efficacy of Aliskiren Compared to Enalapril in Pediatric Hypertensive Patients 6-17 Years of Age

Condition:   HypertensionInterventions:   Drug: Aliskiren;   Drug: EnalaprilSponsors:   Novartis;   Novartis PharmaceuticalsRecruiting - verified January 2013
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials